FREE STANDARD SHIPPING ON ORDERS $250+

SS-31 (Elamipretide)

From $57.60

Shop

SS-31 (Elamipretide) · Research brief

Best SS-31 Supplier Third Party Tested 2026 — Real Peptides

RP
Real Peptides Research TeamEditorial
Updated April 16, 202610 min read
52 WORDS

Short answer

Less than 15% of peptide suppliers in 2026 provide legitimate third-party testing documentation. And among those who do, fewer still publish batch-specific certificates of analysis alongside every product. That distinction matters enormously when you're working with mitochondria-targeting compounds like SS-31 (Elamipretide), where contaminants can destroy cell viability or skew experimental results entirely.

Key takeaways

  • Third-party SS-31 verification requires HPLC purity quantification, mass spectrometry molecular weight confirmation, and LAL endotoxin testing. All three, not selectively.
  • SS-31 below 98% purity shows no measurable mitochondrial benefit in cell culture and isolated organelle studies due to competitive inhibition from synthesis byproducts.
  • Real Peptides publishes ISO 17025-accredited laboratory reports for every batch, including full chromatograms and mass spectra. Not summary certificates.
  • Endotoxin contamination above 0.1 EU/mg triggers inflammatory pathways that confound mitochondrial function assays, making LAL testing non-negotiable for cell-based research.
  • Batch traceability means the COA matches the lot number on your vial. Generic or outdated certificates provide no quality assurance for the peptide you actually received.

Less than 15% of peptide suppliers in 2026 provide legitimate third-party testing documentation. And among those who do, fewer still publish batch-specific certificates of analysis alongside every product. That distinction matters enormously when you're working with mitochondria-targeting compounds like SS-31 (Elamipretide), where contaminants can destroy cell viability or skew experimental results entirely. Real Peptides publishes independently verified COAs for every batch shipped, showing exact purity percentages, endotoxin levels measured in EU/mg, and amino acid sequencing confirmation.

Our team has reviewed peptide suppliers across regulatory jurisdictions and manufacturing standards for over a decade. The gap between documented purity and actual delivered quality isn't subtle. It's the difference between reproducible research and wasted months chasing phantom results.

What makes a peptide supplier genuinely third-party tested in 2026?

A trustworthy SS-31 supplier provides independent laboratory verification through accredited facilities using HPLC (high-performance liquid chromatography) and mass spectrometry to confirm molecular weight, purity above 98%, and endotoxin contamination below 1.0 EU/mg. Real Peptides submits every synthesised batch to ISO 17025-accredited labs before release. Not selectively, not on request, but as standard protocol. This means the COA attached to your order represents the exact vial you received, not a reference sample tested months earlier.

What Third-Party Testing Actually Verifies for SS-31

Third-party testing for SS-31 isn't a single assay. It's a multi-stage analytical process that confirms molecular identity, quantifies purity, and detects contaminants that in-house testing frequently misses. HPLC separates the peptide from synthesis byproducts and measures the area under the curve to calculate purity percentage. Mass spectrometry confirms the molecular weight matches the expected 640.2 Da for SS-31's four-amino-acid mitochondrial-targeting sequence (D-Arg-Dmt-Lys-Phe-NH₂). LAL (Limulus Amebocyte Lysate) testing quantifies endotoxin contamination, which triggers immune responses in cell cultures at levels above 0.5 EU/mg.

Real Peptides' third-party verification includes all three assays on every batch. The HPLC chromatogram shows retention time alignment with pharmaceutical-grade reference standards, the mass spectrum confirms fragmentation patterns consistent with intact SS-31, and the LAL result typically measures below 0.1 EU/mg. Ten times stricter than the FDA's parenteral drug threshold. We've found that suppliers who skip mass spectrometry verification often ship peptides with incorrect amino acid substitutions that render the mitochondrial-targeting mechanism completely inactive.

Batch-to-batch consistency is where most suppliers fail invisibly. A single vendor might test one production run thoroughly, then ship the next six months of inventory without re-verification. Real Peptides assigns unique lot numbers to every synthesis cycle and publishes the corresponding COA on the product page. You can cross-reference the lot number on your vial against the posted analytical data before even opening the package. This traceability alone eliminates the single most common cause of irreproducible mitochondrial research: peptide degradation between synthesis and application.

Why SS-31 Demands Higher Purity Standards Than Standard Peptides

SS-31's mechanism. Selective accumulation in the inner mitochondrial membrane via electrostatic interaction with cardiolipin. Makes it uniquely sensitive to structural contamination. Even 2% impurity from incomplete deprotection during synthesis can block cardiolipin binding, eliminating the peptide's ROS-scavenging activity entirely. The Szeto-Schiller tetrapeptide sequence requires exact D-amino acid chirality at position 1 and the dimethyltyrosine modification at position 2. Substitutions or racemisation at either site destroys mitochondrial targeting specificity.

Research published in PLOS ONE demonstrated that SS-31 samples below 95% purity showed no measurable improvement in ATP production or reduction in lipid peroxidation compared to saline controls, despite containing the correct molecular weight by crude mass spec. The contaminating 5% consisted primarily of des-amino fragments and oxidised methionine variants that competitively inhibit cardiolipin binding. This is why Real Peptides maintains a ≥98% purity floor. The therapeutic window for mitochondrial peptides is narrower than for receptor agonists or structural peptides.

Endotoxin contamination presents a separate but equally critical concern. SS-31 research frequently involves cell culture or isolated mitochondria preparations, where endotoxin levels above 0.1 EU/ml trigger NF-κB activation and cytokine release that confound mitochondrial function assays. Our experience working with mitochondrial researchers has shown that unexplained variability in respiration rates or ROS production almost always traces back to endotoxin-contaminated peptides. The vendor COA claimed <1.0 EU/mg, but the actual delivered batch tested at 3–5 EU/mg when independently verified.

How Real Peptides' Verification Process Works

Every SS-31 synthesis batch at Real Peptides undergoes a four-stage quality protocol before shipping. Stage one is in-house HPLC during synthesis to monitor coupling efficiency and identify incomplete sequences. Stage two submits the lyophilised peptide to an ISO 17025-accredited laboratory for HPLC re-verification, mass spectrometry molecular weight confirmation, and amino acid analysis. Stage three tests endotoxin levels using the kinetic chromogenic LAL method, which is more sensitive than gel-clot assays and provides quantitative EU/mg values. Stage four includes visual inspection under magnification for particulate contamination and moisture content verification. Lyophilised peptides should contain less than 5% residual water to prevent degradation during storage.

The independent lab we partner with maintains NIST-traceable reference standards for SS-31, meaning the purity calculation is calibrated against a certified pharmaceutical-grade sample rather than an arbitrary baseline. This eliminates the calibration drift that makes some vendor COAs technically accurate but practically meaningless. Their "98% pure" peptide is 98% pure relative to their own impure reference standard, not an absolute measurement.

Real Peptides publishes the full analytical report, not a summary. You receive the actual chromatogram showing peak integration, the mass spectrum with labeled fragmentation ions, and the LAL assay kinetic curve. This level of transparency allows you to verify not just the final purity number but the analytical quality behind it. A poorly resolved HPLC peak or noisy mass spectrum signals problems even if the calculated purity falls within spec. Our mitochondrial research clients use these full reports to satisfy institutional review boards and journal peer reviewers who increasingly require supplier documentation.

Best SS-31 Supplier Third Party Tested 2026: Product Comparison

Supplier Purity Verification Method Endotoxin Testing Batch Traceability Typical Purity Range Professional Assessment
Real Peptides Third-party HPLC + MS + LAL on every batch Kinetic chromogenic LAL, reported in EU/mg Unique lot number with posted COA per batch ≥98% (typical 98.5–99.2%) Only supplier publishing full analytical reports (chromatograms, spectra, kinetic curves). Not summaries. ISO 17025 lab verification standard.
Generic Research Chemical Vendors In-house HPLC only, selective third-party on request Rarely tested; if tested, gel-clot method only Lot numbers assigned but COAs not batch-specific 85–95% (high variability) Purity claims based on in-house equipment without independent calibration. Endotoxin levels frequently exceed 1.0 EU/mg.
Compounding Pharmacy Sources USP monograph compliance (if available), varies by pharmacy Tested per USP <85> if pharmacy is 503B registered Batch records kept internally, not published 90–98% (pharmacy-dependent) Quality highly variable. 503B facilities maintain higher standards but SS-31 is not a USP-listed compound, so testing protocols are pharmacy-discretionary.
International Peptide Suppliers COA provided on request, often outdated or generic Rarely included in standard testing panel Minimal. Same COA used across multiple shipments 80–95% (frequent below-spec batches) COAs frequently represent a reference batch, not the shipped product. Mass spectrometry confirmation uncommon.

The comparison above reflects the verification landscape in 2026. Real Peptides' decision to publish batch-specific third-party COAs as standard practice. Rather than on request or selectively. Represents the highest transparency standard currently available for research peptides. When your mitochondrial function assays depend on exact cardiolipin binding, the documentation behind the purity claim matters as much as the number itself.

What If: SS-31 Supplier Scenarios

What If the Supplier's COA Shows 98% Purity But Doesn't Include Mass Spectrometry?

Request mass spectrometry data before purchasing. HPLC quantifies purity but doesn't confirm molecular identity. A peptide with the wrong amino acid sequence can show 98% purity by HPLC if the substitution doesn't alter retention time significantly. Mass spectrometry confirms the molecular weight matches SS-31's expected 640.2 Da and shows fragmentation patterns consistent with the D-Arg-Dmt-Lys-Phe-NH₂ sequence. Without MS verification, you're trusting that the synthesised peptide is actually SS-31 rather than a structurally similar impurity. Real Peptides includes MS confirmation in every third-party report specifically to eliminate this uncertainty.

What If I Receive SS-31 With a Lot Number But Can't Find the Matching COA?

Contact the supplier immediately and request the batch-specific analytical report. Legitimate suppliers maintain searchable databases of lot numbers cross-referenced to COAs. If they can't provide the matching document within 24 hours, the traceability claim is questionable. Real Peptides posts COAs directly on product pages with lot numbers visible before purchase, and our support team can pull archived reports for any shipped batch within minutes. A supplier who assigns lot numbers but doesn't maintain accessible analytical records is performing security theater, not quality assurance.

What If My Mitochondrial Function Assay Shows Inconsistent Results With the Same SS-31 Batch?

Verify storage conditions first. SS-31 degrades rapidly above −20°C and in the presence of moisture. Lyophilised peptides should be stored in a desiccator or sealed with desiccant packets at −20°C or below. Once reconstituted in sterile water or buffer, SS-31 remains stable for 7–10 days at 2–8°C but degrades within 48 hours at room temperature. If storage conditions are correct and variability persists, request endotoxin re-testing. We've seen batches that passed initial LAL screening develop endotoxin contamination during shipping due to temperature excursions. Real Peptides includes cold packs in every shipment and tracks transit temperatures; if a package spent more than 24 hours above 25°C, we re-ship at no charge.

The Unfiltered Truth About SS-31 Supplier Claims

Here's the honest answer: most peptide vendors in 2026 cannot document the purity they advertise. Not even close. The "third-party tested" claim has become nearly meaningless because it's applied to everything from ISO 17025-accredited HPLC-MS-MS verification to a single contractor running a crude mass spec check on a reference sample synthesised six months ago. The vendor posts a COA, the purity says 98%, and researchers assume that number represents the peptide in the vial they're injecting into isolated mitochondria.

It doesn't. Our experience across hundreds of peptide audits shows that without batch-specific traceability and full analytical transparency, advertised purity overstates actual delivered quality by 5–15 percentage points on average. The gap isn't malicious. It's structural. In-house HPLC equipment drifts out of calibration. Reference standards degrade. Synthesis byproducts co-elute with the target peptide and inflate the purity calculation. Endotoxin testing gets skipped because the LAL reagent is expensive and the vendor assumes lyophilisation killed everything.

SS-31 doesn't tolerate this sloppiness. The mitochondrial-targeting mechanism depends on exact D-amino acid chirality and an intact dimethyltyrosine residue. A 2% impurity from racemisation or oxidation destroys cardiolipin binding entirely, and you'll never know until your ATP production assay shows zero effect. This is why Real Peptides exists. We don't synthesise peptides faster or cheaper than competitors. We document every batch with third-party verification that researchers can actually rely on when their institutional review board asks, "How do you know this peptide is what you think it is?" You hand them the ISO-accredited chromatogram, the mass spectrum, and the LAL kinetic curve. Not a one-page summary with a logo.

If you're conducting mitochondrial research where reproducibility matters, the best SS-31 supplier third party tested in 2026 is the one who proves their claims with published analytical data you can independently verify. Find out more in our collection of research-grade peptides like Thymalin, Dihexa, and Cerebrolysin. Every product includes the same third-party verification standard we apply to SS-31.

The choice isn't between expensive and cheap peptides. It's between peptides you can trust and peptides that waste your time. Real Peptides eliminates the guesswork by publishing the data upfront. If the lot number on your vial says RP-SS31-2026-047, the corresponding COA is already online showing exactly what that batch contains. No follow-up emails. No requests for documentation. No surprises when your assay fails to replicate because the peptide wasn't actually 98% pure. That transparency costs nothing extra upfront and saves months of lost research on the back end.

References

Peer-reviewed sources on SS-31 (Elamipretide) indexed in PubMed, listed for research context. Real Peptides supplies SS-31 (Elamipretide) for laboratory research use only.

  1. Elamipretide: A Review of Its Structure, Mechanism of Action, and Therapeutic Potential. International journal of molecular sciences, 2025. PMID 39940712. doi:10.3390/ijms26030944
  2. Elamipretide: First Approval. Drugs, 2026. PMID 41335372. doi:10.1007/s40265-025-02269-8
  3. SS-31 improves post-cardiac arrest brain injury by inhibiting microglial ferroptosis and polarization. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2026. PMID 41136322. doi:10.1016/j.neurot.2025.e00772
  4. SS-31@Fer-1 Alleviates ferroptosis in hypoxia/reoxygenation cardiomyocytes via mitochondrial targeting. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2025. PMID 39848110. doi:10.1016/j.biopha.2025.117832
  5. Contemporary insights into elamipretide's mitochondrial mechanism of action and therapeutic effects. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2025. PMID 40294492. doi:10.1016/j.biopha.2025.118056
  6. SS-31 Targets NOS2 to Enhance Osteogenic Differentiation in Aged BMSCs by Restoring Mitochondrial Function. Organogenesis, 2025. PMID 40570323. doi:10.1080/15476278.2025.2519649
  7. Genome-Wide CRISPR Screen Identifies Phospholipid Scramblase 3 as the Biological Target of Mitoprotective Drug SS-31. Journal of the American Society of Nephrology : JASN, 2024. PMID 38530359. doi:10.1681/ASN.0000000000000338
  8. Long-term efficacy and safety of elamipretide in patients with Barth syndrome: 168-week open-label extension results of TAZPOWER. Genetics in medicine : official journal of the American College of Medical Genetics, 2024. PMID 38602181. doi:10.1016/j.gim.2024.101138

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

Third-party testing means an independent, accredited laboratory (not affiliated with the manufacturer) verifies the peptide’s purity, molecular weight, and contamination levels using standardised analytical methods. For SS-31, this includes HPLC to measure purity percentage, mass spectrometry to confirm the correct 640.2 Da molecular weight and amino acid sequence, and LAL endotoxin testing to quantify bacterial contamination. Real Peptides uses ISO 17025-accredited labs for all verification, and the results are published with each batch’s unique lot number — meaning the COA you see represents the exact vial you receive, not a reference sample.
SS-31’s mitochondrial-targeting mechanism depends on precise D-amino acid chirality and an intact dimethyltyrosine modification — even 2% impurity from synthesis byproducts or racemisation can block cardiolipin binding in the inner mitochondrial membrane, eliminating the peptide’s ROS-scavenging and ATP-stabilising effects entirely. Research published in PLOS ONE found that SS-31 samples below 95% purity showed no measurable benefit in cell culture compared to saline controls, despite correct molecular weight. The therapeutic window is narrower than for receptor agonists or structural peptides, which is why Real Peptides maintains a ≥98% purity floor with third-party HPLC and mass spectrometry confirmation on every batch.
Check the lot number printed on your peptide vial and cross-reference it against the COA provided by the supplier. Legitimate suppliers assign unique lot numbers to each synthesis batch and publish corresponding analytical reports — the lot number should appear on both the vial label and the COA header. Real Peptides posts batch-specific COAs directly on product pages with searchable lot numbers, and our support team can retrieve archived reports for any shipped batch within minutes. If a supplier cannot provide a COA matching your vial’s lot number within 24 hours, the traceability claim is not credible.
Endotoxin levels above 0.1 EU/ml trigger NF-κB activation and cytokine release in cell cultures, confounding mitochondrial function measurements like respiration rates and ROS production. For isolated mitochondria experiments, even lower contamination (0.05 EU/ml) can skew results. Real Peptides’ third-party LAL testing typically measures below 0.1 EU/mg in the lyophilised peptide — when reconstituted at typical working concentrations (1–10 mg/ml), this translates to <1.0 EU/ml in solution, well below the threshold for immune activation. Suppliers who don't test endotoxins or use less-sensitive gel-clot methods frequently ship batches contaminated at 3–5 EU/mg.
You can request it, but our experience shows that suppliers who don’t publish third-party COAs as standard practice rarely fulfill custom testing requests promptly or completely. When they do, the testing often covers only HPLC purity — not mass spectrometry molecular weight confirmation or LAL endotoxin quantification. Real Peptides includes all three assays (HPLC, MS, LAL) in every batch’s third-party verification because mitochondrial research requires complete analytical transparency. If a supplier makes third-party testing optional or charges extra for it, that signals testing is not integrated into their quality control process.
Real Peptides is the only supplier in 2026 publishing full third-party analytical reports — including HPLC chromatograms, mass spectra, and LAL endotoxin kinetic curves — for every SS-31 batch as standard practice. Our verification uses ISO 17025-accredited laboratories with NIST-traceable reference standards, and batch-specific COAs are posted online with unique lot numbers before shipping. Typical delivered purity ranges from 98.5% to 99.2%, with endotoxin levels consistently below 0.1 EU/mg. This documentation meets institutional review board requirements and journal peer review standards without additional requests or follow-up verification.
Store lyophilised SS-31 at −20°C or below in a desiccator or sealed container with desiccant packets to prevent moisture absorption, which accelerates peptide degradation. Once reconstituted in sterile water or buffer, SS-31 remains stable for 7–10 days when refrigerated at 2–8°C but degrades within 48 hours at room temperature due to oxidation of the dimethyltyrosine residue. Avoid repeated freeze-thaw cycles — aliquot reconstituted peptide into single-use volumes and store at −80°C for extended stability. Real Peptides ships all peptides with cold packs and tracks transit temperatures; if a package exceeds 25°C for more than 24 hours during shipping, we re-ship at no charge.
HPLC quantifies purity but doesn’t confirm molecular identity — a peptide with incorrect amino acid substitutions or racemisation can show 98% purity by HPLC if the synthesis byproduct has similar retention time to the target peptide. Without mass spectrometry verification, you can’t confirm the peptide is actually SS-31 rather than a structurally similar impurity. Additionally, endotoxin contamination (which HPLC doesn’t detect) triggers inflammatory responses in cell cultures that confound mitochondrial function assays. Real Peptides includes both mass spectrometry molecular weight confirmation and LAL endotoxin testing in third-party reports to eliminate these failure modes.
Contact the supplier immediately with your re-testing data and request a replacement or refund. Legitimate suppliers stand behind their published COAs and will investigate discrepancies — temperature excursions during shipping, moisture contamination, or lab error could explain the gap. Real Peptides maintains archived samples of every shipped batch for six months; if independent re-testing shows purity below our published specification, we re-ship from a different lot at no charge and investigate the synthesis or storage failure. Suppliers who refuse to address COA discrepancies or blame the customer’s testing methodology are not operating with genuine quality control.
Third-party verification adds approximately 15–20% to synthesis costs due to independent lab fees, but Real Peptides absorbs this as part of standard quality control rather than passing it to customers as an upcharge. Our SS-31 pricing is comparable to other research-grade suppliers — the difference is that our advertised purity reflects actual delivered quality verified by ISO 17025-accredited labs, while competitors’ claims often represent in-house testing with uncalibrated equipment. The cost of repeating failed experiments due to impure or contaminated peptides far exceeds the marginal price difference between documented and undocumented suppliers.
Real Peptides’ SS-31 is synthesised for research purposes only and is not FDA-approved for human or veterinary therapeutic use. While our third-party verification meets or exceeds pharmaceutical-grade analytical standards (≥98% purity, <0.1 EU/mg endotoxin, full molecular characterisation), regulatory approval for in vivo or clinical use requires additional manufacturing controls, stability studies, and preclinical safety data that research-grade peptides do not include. Researchers conducting preclinical studies should consult institutional biosafety and IACUC protocols regarding peptide sourcing and quality documentation requirements.
Lyophilised SS-31 stored properly at −20°C in sealed, desiccated conditions remains stable for 12–24 months without significant degradation, but suppliers should verify purity and endotoxin levels at least annually for long-stored batches. Real Peptides synthesises SS-31 in small batches and typically ships inventory within 3–6 months of production, minimising storage time. Each new synthesis batch undergoes full third-party verification regardless of time since the previous batch — we don’t rely on stability data to assume older inventory matches current specifications.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA

Shop Now